Shares of
Bionano Genomics (NASDAQ:BNGO) hit a record high on Friday. By the close of trading, the genome analysis company s stock price was up 17%.
So what
On Thursday, Bionano Genomics released a study showing that its Saphyr optical genome mapping (OGM) system could be used to analyze a wide variety of solid tumors in cancer research. In every sample tested, Saphyr was able to identify structural variants (SVs) affecting key cancer genes. OGM will yield unprecedented insights into solid tumor diagnosis and treatment, study lead Dr. James Broach said in a press release.
Image source: Getty Images. Dr. Broach s work now demonstrates that Saphyr is uniquely capable of identifying clinically important SVs in solid tumor samples as well and that it does so with a simple, automated analysis workflow, Bionano CEO Erik Holmlin said.
Erik-holmlin
Digital-health
Bionano-genomics
James-broach
Life-science
Diagnostic-tools-conference
டிஜிட்டல்-ஆரோக்கியம்
ஜேம்ஸ்-புரோச்
வாழ்க்கை-அறிவியல்
கண்டறியும்-கருவிகள்-மாநாடு